Cantor's Louise Chen breaks down new Medicare drug pricing negotiations

Cantor's Louise Chen breaks down new Medicare drug pricing negotiationsПодробнее

Turning point in drug prices is around the corner, says Cantor Fitzgerald's Louise ChenПодробнее

White House unveils first 10 drugs subject to Medicare price negotiationsПодробнее

Eli Lilly is a 'multi-diversified drugmaker', says Cantor Fitzgerald's Louise ChenПодробнее

U.S. announces first 10 drugs for Medicare price negotiationПодробнее

AstraZeneca uncertainty will give market unease: Cantor Fitzgerald's Louise ChenПодробнее

Medicare drug price negotiations could save government billionsПодробнее

There's still a long runway for obesity drugs, says Cantor Fitzgerald's Louise ChenПодробнее

Medicare’s New Drug Price Negotiation Program: 2023 Health Policy Speaker SeriesПодробнее

Cantor Fitzgerald's Chen on J&J split: It's a more focused, nimble companyПодробнее

Transparency in Drug Supply Chains | Dan LiljenquistПодробнее

Cardiologist and singer-songwriter is healing people through the power of medicine, musicПодробнее

Rep. Luján Discussing Lowering the Cost of Prescription DrugsПодробнее

Biden and Harris praise negotiations to lower Medicare drug costsПодробнее

Episode 51 – Drug Pricing: Final IRA Price Negotiation Guidance – How CMS Addressed the Part D/B ...Подробнее

How a potential Senate deal could lower health care costs for millions of AmericansПодробнее

June Medical Services LLC v. Russo DecisionПодробнее

Medicare negotiates historic drug price cutsПодробнее

BMO's Evan Seigerman discusses unintended consequences from Medicare drug cost battleПодробнее

Generic drug makers accused of price fixingПодробнее